How AstraZeneca Adapts Strategic Decision Making for Resilience

This episode explores:

• The fundamentals of strategic decision making for AstraZeneca. (1:16)
• How AstraZeneca adapts its supply chain to drive both cost optimization and business growth. (4:20)
• Timing investments in new assets and their associated capabilities. (11:09)
• Methods to encourage talent to join change management journeys. (13:50)
• Recommendations for supply chain leaders working to understand their organization’s unique underpinnings for decision making. (16:30)

Host Thomas O’Connor and guest Matt Winterman, AstraZeneca’s senior vice president of global supply chain and strategy, discuss AstraZeneca’s approach to strategic decision making in regards to resilience. They explore AstraZeneca’s focus on supply chain design as a vehicle for growth and cost optimization, as well as the trigger points that underpin their decision-making processes. They close the show with three recommendations for supply chain leaders to apply similar principles to their own organizations.

Matthew Winterman joined AstraZeneca in 2023 and is the senior vice president of global supply chain and strategy, with overall responsibility for the development and execution of the end-to-end supply chain platform and product supply strategies. In addition, he is responsible for ensuring the strategic development of network designs and supply chain capabilities supporting AstraZeneca’s global operational network. He reports into the EVP of operations and IT and chief sustainability officer and serves as a member of the global operations senior leadership team.